| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥43.5B | ¥36.7B | +18.3% |
| Operating Income | ¥2.9B | ¥2.9B | +2.2% |
| Ordinary Income | ¥3.6B | ¥3.4B | +5.7% |
| Net Income | ¥3.7B | ¥3.4B | +7.8% |
| ROE | 3.8% | 3.8% | - |
FY2026 Q3 results: Revenue 4,350 million yen (YoY +18.3%), Operating Income 291 million yen (YoY +2.2%), Ordinary Income 356 million yen (YoY +5.7%), Net Income 369 million yen (YoY +7.8%). The company achieved robust top-line growth while profitability improved at a modest pace. Total assets decreased to 14,894 million yen from 16,360 million yen, while total equity increased to 9,665 million yen from 9,103 million yen, reflecting balance sheet restructuring with reduced working capital and investment securities. Cash position strengthened to 3,965 million yen from 3,029 million yen YoY. Gross profit margin stood at 25.6% with gross profit of 1,113 million yen, while SG&A expenses of 822 million yen resulted in an operating margin of approximately 6.7%. The company maintains no dividend policy with zero payout for the period.
Revenue increased 683 million yen (+18.3%) YoY to 4,350 million yen, driven by sales recovery in core operations. The significant top-line expansion reflects either improved order intake or market demand recovery, though specific segment breakdown is not disclosed in the available data. Despite the robust revenue growth, operating income increased only 6 million yen (+2.2%) to 291 million yen, indicating margin compression at the operating level. The operating margin of 6.7% suggests that SG&A expenses and cost of sales increased proportionally or faster than revenue growth. Gross profit margin of 25.6% provides baseline profitability, but the conversion to operating profit remains constrained.
Ordinary income reached 356 million yen (+5.7%), representing 6.5 million yen improvement from operating income through net non-operating gains of approximately 65 million yen. Non-operating income composition includes financial income and equity method gains as primary components. Net income of 369 million yen (+7.8%) exceeded ordinary income due to extraordinary items: extraordinary gains of 233 million yen and extraordinary losses of 208 million yen resulted in net positive contribution of 25 million yen. Asset disposal gains and investment securities sales contributed to extraordinary gains, while the effective tax rate of approximately 3.2% reflects tax adjustments or deferred tax benefits. The net income growth of 7.8% outpaced operating income growth of 2.2%, indicating bottom-line improvement was partially supported by non-recurring factors.
This represents a revenue up/profit up pattern, though the disconnect between revenue growth (+18.3%) and operating profit growth (+2.2%) signals deteriorating operating leverage or cost structure challenges requiring management attention.
[Profitability] ROE of 3.8% reflects modest equity returns, decomposed into net profit margin 8.5%, total asset turnover 0.292, and financial leverage 1.54x. Operating margin stands at approximately 6.7%, calculated from operating income of 291 million yen on revenue of 4,350 million yen. Gross margin of 25.6% indicates baseline product profitability before SG&A expenses. ROIC of approximately 4.0% demonstrates limited return on invested capital. The effective tax rate of 3.2% is notably low due to tax adjustments or deferred tax assets. [Cash Quality] Cash and cash equivalents of 3,965 million yen provide coverage of 1.10x against short-term liabilities of 3,618 million yen. Working capital management shows receivables of 2,878 million yen and payables of 2,455 million yen. Inventory decreased significantly to 2 million yen from 19 million yen YoY, representing 91.1% reduction. [Investment Efficiency] Total asset turnover of 0.292 remains low, constraining ROE despite improved profitability. Investment securities decreased 31.8% to 1,606 million yen, reflecting portfolio rationalization. Property, plant and equipment increased 33.5% to 2,628 million yen, with construction in progress of 1,220 million yen indicating ongoing capital investment. [Financial Health] Equity ratio of 64.9% (equity 9,665 million yen / total assets 14,894 million yen) demonstrates conservative capitalization. Current ratio of 264.8% (current assets 9,579 million yen / current liabilities 3,618 million yen) indicates strong liquidity. Interest-bearing debt of 1,259 million yen yields debt-to-equity ratio of 0.13x, reflecting minimal leverage. Debt capital ratio of 11.5% confirms low financial risk profile.
Cash and deposits increased 936 million yen YoY (+30.9%) to 3,965 million yen, indicating improved liquidity position. The cash accumulation reflects operating profit generation combined with significant balance sheet restructuring. Receivables decreased 1,672 million yen (-36.8%) to 2,878 million yen, suggesting accelerated collection or reduced credit sales, which contributed positively to cash inflows. Payables decreased 1,798 million yen (-42.3%) to 2,455 million yen, representing faster supplier payments and cash outflow, though this may reflect improved payment terms or reduced procurement volume. Investment securities declined 749 million yen (-31.8%), generating cash proceeds from portfolio liquidation and contributing extraordinary gains of 25 million yen from securities sales. Capital investment is evidenced by property, plant and equipment increase of 660 million yen (+33.5%), with construction in progress of 1,220 million yen indicating ongoing expansion projects. Inventory compression of 17 million yen (-91.1%) released working capital. The net effect shows strong liquidity with cash coverage of short-term liabilities at 1.10x and current ratio of 264.8%, providing adequate financial flexibility despite active investment and working capital optimization.
Ordinary income of 356 million yen versus operating income of 291 million yen shows non-operating net contribution of approximately 65 million yen, representing 1.5% of revenue. This comprises primarily financial income and equity method gains as stable recurring components. Extraordinary items showed net positive impact of 25 million yen (extraordinary gains 233 million yen less extraordinary losses 208 million yen), with investment securities sales gains of 25 million yen as the primary component. Non-recurring items represent approximately 0.6% of revenue, indicating limited reliance on one-time gains for bottom-line results. The effective tax rate of 3.2% is exceptionally low, reflecting deferred tax benefits or tax adjustments that may not recur at similar magnitude. While cash position increased 936 million yen YoY, the quality of earnings conversion is partially obscured by working capital timing effects, as both receivables and payables decreased significantly. The disconnect between operating income growth (+2.2%) and revenue growth (+18.3%) suggests operating earnings quality faces margin pressure. Net income of 369 million yen benefited from tax efficiency and modest extraordinary gains, but core operating profitability improvement remains limited, warranting focus on sustainable margin expansion.
Full-year guidance projects revenue of 5,100 million yen, operating income of 300 million yen, ordinary income of 350 million yen, and net income of 330 million yen. Q3 cumulative results show revenue of 4,350 million yen (85.3% progress rate), operating income of 291 million yen (97.0% progress rate), ordinary income of 356 million yen (101.7% progress rate), and net income of 369 million yen (111.8% progress rate). Operating income has already achieved 97.0% of full-year target at Q3, indicating either conservative initial guidance or expected Q4 deceleration. The ordinary income progress rate of 101.7% and net income progress rate of 111.8% both exceed full-year forecasts, suggesting potential for upward revision or Q4 profit decline. The year-on-year guidance changes show revenue decline of 3.4%, operating income decline of 7.3%, ordinary income decline of 4.4%, and net income decline of 8.4%, indicating management expects full-year performance below prior year despite strong Q3 YoY growth. This disconnect suggests either Q4 headwinds or comparison base effects from prior year structure. The advanced progress rates for profit metrics relative to standard 75% Q3 benchmark suggest frontloaded earnings, requiring monitoring of Q4 execution and potential guidance adjustment.
Operating margin compression risk: Operating income grew only 2.2% despite revenue growth of 18.3%, resulting in margin decline from approximately 7.9% to 6.7%. Continued cost pressure or inability to leverage fixed costs could further erode profitability and threaten the company's ability to generate sustainable returns above cost of capital.
Working capital efficiency deterioration: Receivables turnover extends to 242 days (DSO) and inventory turnover to 244 days (DIO), resulting in cash conversion cycle exceeding industry norms. While absolute receivables decreased YoY, the extended collection period indicates structural inefficiency that ties up capital and increases credit risk exposure.
Capital investment return uncertainty: Construction in progress of 1,220 million yen represents 8.2% of total assets and 46.4% of property, plant and equipment. Delayed project completion, cost overruns, or failure to achieve planned returns could result in impairment risk and further depress already-low ROIC of 4.0%.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin 6.7% underperforms industry median 8.3% (IQR: 4.8%-12.6%), positioning the company in the lower quartile for operating efficiency. Net profit margin of 8.5% exceeds industry median 6.3% (IQR: 3.2%-9.0%), though this reflects favorable tax treatment rather than superior operating performance. ROE of 3.8% falls below industry median 5.0% (IQR: 2.9%-8.1%), indicating below-average equity returns. ROIC of 4.0% approximates industry median 5.0% (IQR: 3.0%-10.0%) but remains in the lower half, confirming suboptimal capital efficiency.
Financial Health: Equity ratio of 64.9% aligns closely with industry median 63.8% (IQR: 49.5%-74.7%), demonstrating comparable conservative capitalization. Current ratio of 264.8% substantially exceeds industry median 284.0% (IQR: 210.0%-381.0%), though within normal range for manufacturing sector. Net debt position is negative (cash exceeds debt), comparing favorably to industry median Net Debt/EBITDA of -1.11.
Efficiency: Asset turnover of 0.292 significantly underperforms industry median 0.58 (IQR: 0.42-0.66), placing the company in the bottom quartile and representing the primary constraint on ROE. Receivables turnover of 242 days substantially exceeds industry median 83 days (IQR: 68-115 days), indicating collection efficiency challenges. Payables turnover of 141 days also exceeds industry median 56 days (IQR: 42-90 days). Working capital turnover metrics suggest extended cash conversion cycles relative to peers.
Growth: Revenue growth of 18.3% substantially outperforms industry median 2.7% (IQR: -1.9%-7.9%), positioning the company in the top quartile for top-line expansion. However, this growth has not translated to proportional operating profit improvement, suggesting margin dilution from growth investments.
(Industry: Manufacturing, n=98 companies, Comparison: 2025-Q3 median and interquartile ranges, Source: Proprietary analysis)
Strong revenue momentum with structural profitability challenges: The company achieved 18.3% revenue growth, substantially exceeding the manufacturing industry median of 2.7%, demonstrating competitive strength in market share capture or demand recovery. However, operating income growth of only 2.2% reveals margin compression, with operating margin of 6.7% underperforming industry median of 8.3%. The widening gap between top-line and bottom-line growth rates indicates operating leverage deterioration that requires strategic cost management or pricing power improvement to restore sustainable profitability.
Capital efficiency requires structural improvement: ROE of 3.8% and ROIC of 4.0% both trail industry benchmarks and cost of capital, driven primarily by asset turnover of 0.292 versus industry median of 0.58. The company's asset base is disproportionately large relative to sales generation, with construction in progress of 1,220 million yen representing significant capital deployed but not yet productive. Combined with extended working capital cycles (DSO 242 days vs industry median 83 days, DIO 244 days), the company faces structural capital efficiency challenges that constrain returns regardless of sales growth. Successful completion and ramp-up of capital projects, coupled with working capital optimization, represent critical improvement pathways.
Conservative financial position provides strategic flexibility: Equity ratio of 64.9%, current ratio of 264.8%, and minimal debt-to-equity of 0.13x position the company among the financially healthiest in the manufacturing sector. Cash position of 3,965 million yen exceeds short-term liabilities and provides flexibility for growth investment, shareholder returns, or economic downturn resilience. The zero dividend policy reflects prioritization of internal reinvestment, though the substantial cash balance and modest capital requirements suggest capacity for future shareholder return programs once capital efficiency improvements demonstrate sustainable value creation.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.